Drug Profile
Research programme: bacterial DNA polymerase III inhibitors - Galapagos
Alternative Names: CAM 1; GLPG 1492Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Galapagos NV
- Class
- Mechanism of Action DNA polymerase III inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Methicillin-resistant Staphylococcus aureus infections